Sasol Limited (SSL): what the price assumes

boothcheck covers Sasol Limited (SSL) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-11.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/SSL

Headline

FieldValue
TickerSSL
CompanySasol Limited
Sector / IndustryEnergy
Current price$10.94/sh
CompositionSale of products 98% / Services rendered 2%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)5.1%
Operating margin today7.6%
Margin compression (value-band)-2.5pp
Multiple paid9x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 7.2% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history+0.51σ
implied end-window share0%

Valuation X-Ray

The price is supported by earnings-power and relative-multiple and growth-DCF value, while asset-based lands below the price. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.55x5expensive
Earnings0.73x3justifies
Relative0.54x3justifies
Growth0.71x3justifies

Families that justify the price: Earnings, Relative, Growth Families that call it expensive: Asset

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.3%); the inversion above states its own rate.

Per-Model Detail (n=14)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$27.600.40xyesFCF base $0.7B, growth 7% (input: historical growth), terminal g 4.0%, WACC 9.3%, 5yr projection
DCF Exit MultipleGrowth$15.360.71xyesExit EV/EBITDA: 4.0x / 2.7x / 7.7x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$12.440.88xyesP/E 12.01x (blended: static sector reference 10x + trailing (TTM) 17x), scenarios: 9.0x / 12.0x / 14.4x (bear / base = reference held flat / bull), EV/EBITDA 4.67x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$7.071.55xyesBV/sh $13.35, ROE (TTM) 4.9%, ke 9.3%
Two-Stage Excess ReturnAsset$4.812.27xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$9.371.17xyesRev $13.5B, growth 7% (input: historical growth; tapered), Terminal P/S: 0.4x / 0.5x / 0.6x (bear / base = today's held flat / bull, cap 6x)
Growth-Adjusted P/ERelativeno
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$14.900.73xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.98B × (1−37%) / WACC 9.3% → EPV (no growth)
Residual IncomeAsset$4.512.42xyesBV $13.35 + 5yr PV of (ROE (TTM) 4.9% − Kₑ 9.3%) × BV; BV grows 3.2%/yr
Graham NumberAsset$13.120.83xyes√(22.5 × EPS $0.57 × BVPS $13.35) — Graham's conservative floor
EV/EBITDA RelativeRelative$20.160.54xyesEBITDA $1.77B × sector EV/EBITDA 6.0x
FCF YieldEarnings$15.350.71xyesFCF $700.7M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$0.4822.78xyesEPS $0.57 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/BAsset$14.660.75xyesBV $13.35 × (ROIC 10.2% / WACC 9.3%)
P/Sales SectorRelative$25.320.43xyesRevenue $13.46B × sector P/S 1.2x
PEG Fair ValueRelativeno
Earnings YieldEarnings$6.191.77xyesEPS $0.57 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net debt$3.8b
Net debt / NOPAT (after-tax)5.26x
Net debt / operating income (pre-tax)3.31x
Interest coverage2.0x
Share count CAGR (dilution)0.7%
Burning cashno

Bullet Takeaways

Bull Case

The earnings trajectory turned in a way the price has not fully caught up to. For the six months ended December 2025, Sasol generated positive free cash flow for the first time in four years, more than doubling the prior period, even as headline earnings fell. Cash generation is what matters for a company that spent years carrying too much debt, and the swing to positive free cash flow is the single most important change in the story. Secunda, the coal-to-liquids heart of the business, lifted production about 10% as the new destoning plant reached beneficial operation in December 2025 and gasifier availability improved. Higher volumes from the same asset base is the cleanest form of operating leverage.

The balance sheet is finally being managed to a rule rather than a hope. Sasol carried net debt of about R63.3 billion, roughly $3.8 billion, at the half, and it withheld the interim dividend specifically because net debt sat above the $3.0 billion policy threshold. That discipline, withholding cash returns until debt clears a stated line, is what a deleveraging story should look like, and it protects the equity from a forced raise. On the reported balance sheet the South African operating company shows a large liquid-asset position, and interest coverage of about 2.1 times gives the company room to keep grinding debt down.

Hedging removes the tail that has repeatedly hurt Sasol holders. The company completed its FY2026 hedging with an oil floor near $59 a barrel and has already hedged more than 45% of expected FY2027 production. That floor caps the downside on the commodity that drives the printer. Add a management team tracking its capital-markets-day targets and a renewable build toward 2 gigawatts by 2030, and the bull case is straightforward: a deeply cyclical asset base, hedged on the downside, throwing off cash again, with debt reduction the near-term use of that cash. JPMorgan's upgrade from Underweight to Overweight, lifting the target sharply, reflects that shift in cash and sentiment.

Bear Case

The structural truth for Sasol is that the price sits below where several methods say the operating business is worth, and that is not always a bargain. The earnings-power and relative-multiple methods land above the current $10.48, near $15 on capitalized free cash flow and roughly $20 on sector EV/EBITDA, while the asset methods are far lower. When the value families say cheap and the asset-adjusted lenses say the equity is thin, the market is usually pricing something the trailing numbers do not: in Sasol's case, a coal-to-liquids franchise exposed to carbon regulation, a volatile rand, and a South African operating and political backdrop that raises the return investors demand.

Earnings quality has been poor even as cash improved. Headline earnings per share fell sharply at the half, adjusted EBITDA declined about 12%, and operating profit fell more than 50%, dragged by impairments. A company can generate cash while its accounting earnings collapse under write-downs, and the impairment cadence is itself a signal that parts of the asset base are worth less than the balance sheet once carried. Trailing operating margin near 7% is thin for an integrated energy and chemicals producer, and it leaves little cushion when oil, chemical spreads, or the rand move against the company.

The commodity and currency leverage cuts both ways, and the hedge is only a partial shield. The FY2026 floor near $59 protects part of the downside, but only about 45% of FY2027 is hedged, so a sustained slide in oil or chemical prices in the next cycle would still land on earnings and, through the policy threshold, on the dividend that remains withheld. The debt itself is the overhang: until net debt clears the $3.0 billion line, cash goes to lenders, not owners, and holders wait. The stock has already run hard in 2026 on the oil recovery and the JPMorgan upgrade, which means the easy re-rating from washed-out sentiment is largely behind it. What remains is a cyclical, carbon-heavy balance-sheet-repair story where the next commodity downturn resets the clock.

Valuation

Sasol is a deep-cyclical where the methods that read trailing cash flow say the equity is worth more than $10.48, and the asset-adjusted methods say it is worth much less. Capitalizing free cash flow of about $701 million at the required return reaches roughly $15, a normalized earnings-power value lands near $15, and a sector EV/EBITDA on trailing EBITDA of about $1.77 billion reaches near $20. Against those, the price looks like a discount. But the excess-return and residual-income methods, which charge the business for the roughly 9% return equity demands against a trailing return on equity near 5%, land well below the price, closer to $5 to $7. The split is the whole story: on cash flow Sasol looks cheap, on the return it actually earns on its book it looks fully valued. For a cyclical, the honest read is that trailing cash flow reflects a recovering oil price and a one-time volume lift, not a through-cycle norm.

The most concrete framing is the return the business earns versus its cost. Book value is about $13.35 per share and trailing return on equity is roughly 5%, below the roughly 9% required, so on a pure return basis the equity should trade below book, and at $10.48 it does, near 0.8 times book. That is the market pricing the carbon, currency, and country risk directly. The forward optionality, the destoning-plant volume gains, the renewable build, and continued deleveraging, is what a buyer at today's price is really underwriting.

Solvency is the pivot. The reported operating company shows a large liquid-asset balance and interest coverage near 2.1 times, but the group carries net debt of about $3.8 billion, above the $3.0 billion policy threshold that is currently suspending the dividend. The company is not burning cash, and the swing to positive free cash flow is the crucial improvement, but until debt clears that line the equity holder is behind the lender in the queue. The price makes a cyclical bet: that oil holds near the hedged floor, that Secunda volumes stay up, and that the debt keeps falling toward the level where cash returns resume.

Catalysts

The half-year results for the six months ended December 2025 framed the current setup: turnover of about R122.4 billion, adjusted EBITDA down roughly 12%, operating profit down more than 50% on impairments, and headline EPS sharply lower, but free cash flow positive for the first time in four years. The interim dividend was withheld because net debt of about $3.8 billion remained above the $3.0 billion policy threshold. The next milestone is the full-year FY2026 result and any move in net debt toward the level that would restart cash returns.

Operations and hedging are the swing factors. Secunda production rose about 10% after the destoning plant reached beneficial operation in December 2025, and management says it is tracking its capital-markets-day targets. On hedging, FY2026 is complete with an oil floor near $59 a barrel and more than 45% of FY2027 production already hedged. Sentiment has shifted: JPMorgan upgraded the stock from Underweight to Overweight and raised its target sharply, citing the oil recovery and improved cash generation. The forces to watch are oil prices against the hedge floor, the rand, and whether deleveraging stays on track.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Sasol H1 FY26 results, 2026 · Sasol operational update, 2026 · Sasol H1 FY26 results · Sasol hedging update, 2026 · JPMorgan research, March 2026

View the full interactive SSL report on boothcheck